KPV (Lys-Pro-Val)

KPV (Lys-Pro-Val) is a C-terminal tripeptide fragment of α-MSH, an endogenous neuropeptide and potent anti-inflammatory mediator. The molecular structure of KPV consists of lysine, proline, and valine amino acid residues in sequence. This specific sequence is believed to confer its biological activity, distinct from the full α-MSH molecule, yet retaining some of its immunomodulatory characteristics. Research into KPV's properties has explored its potential mechanisms of action, including modulation of cytokine production and inhibition of NF-κB activation pathways. Early studies suggest KPV may exert its effects through interactions with cellular components involved in inflammatory responses, such as immune cells and epithelial cells. Its small size and specific amino acid sequence contribute to its biochemical characteristics, facilitating investigations into its cellular uptake and stability. Historically, the study of α-MSH fragments has aimed to identify minimal sequences retaining desired biological activities. KPV emerged as a subject of interest due to its observed anti-inflammatory effects in various experimental settings without exhibiting the melanotropic activity of the parent hormone. Current research continues to delineate the precise molecular targets and signaling pathways through which KPV mediates its observed effects, contributing to a deeper understanding of peptide-mediated immunomodulation. Laboratory applications for KPV include studies on inflammation models, investigations into antimicrobial mechanisms, and research exploring peptide-based therapeutic strategies. Researchers utilize KPV to probe cellular responses to inflammatory stimuli and to examine its interactions with microbial agents in controlled experimental environments.